全文获取类型
收费全文 | 1464392篇 |
免费 | 101783篇 |
国内免费 | 2384篇 |
专业分类
耳鼻咽喉 | 21059篇 |
儿科学 | 44494篇 |
妇产科学 | 39136篇 |
基础医学 | 227698篇 |
口腔科学 | 40835篇 |
临床医学 | 130216篇 |
内科学 | 271286篇 |
皮肤病学 | 31534篇 |
神经病学 | 112504篇 |
特种医学 | 58005篇 |
外国民族医学 | 221篇 |
外科学 | 225159篇 |
综合类 | 31862篇 |
现状与发展 | 4篇 |
一般理论 | 398篇 |
预防医学 | 109471篇 |
眼科学 | 34084篇 |
药学 | 111071篇 |
1篇 | |
中国医学 | 2847篇 |
肿瘤学 | 76674篇 |
出版年
2018年 | 15172篇 |
2017年 | 11778篇 |
2016年 | 13854篇 |
2015年 | 14999篇 |
2014年 | 20242篇 |
2013年 | 31293篇 |
2012年 | 43141篇 |
2011年 | 46842篇 |
2010年 | 27007篇 |
2009年 | 23729篇 |
2008年 | 44122篇 |
2007年 | 48113篇 |
2006年 | 47162篇 |
2005年 | 46181篇 |
2004年 | 44966篇 |
2003年 | 43620篇 |
2002年 | 42139篇 |
2001年 | 59772篇 |
2000年 | 62050篇 |
1999年 | 50682篇 |
1998年 | 15153篇 |
1997年 | 13429篇 |
1996年 | 13214篇 |
1995年 | 12347篇 |
1994年 | 11648篇 |
1992年 | 40154篇 |
1991年 | 41022篇 |
1990年 | 40623篇 |
1989年 | 39493篇 |
1988年 | 36650篇 |
1987年 | 36389篇 |
1986年 | 34214篇 |
1985年 | 33305篇 |
1984年 | 25530篇 |
1983年 | 21754篇 |
1982年 | 13161篇 |
1981年 | 12126篇 |
1979年 | 25301篇 |
1978年 | 18331篇 |
1977年 | 15253篇 |
1976年 | 14761篇 |
1975年 | 16650篇 |
1974年 | 19871篇 |
1973年 | 19061篇 |
1972年 | 17938篇 |
1971年 | 16818篇 |
1970年 | 15951篇 |
1969年 | 15204篇 |
1968年 | 13953篇 |
1967年 | 12740篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
62.
L.‐Q. Zheng X.‐C. Han Y. Huang H.‐W. Li X.‐D. Niu J. Li 《Clinical and experimental dermatology》2015,40(3):293-297
Porocarcinoma is an unusual, locally aggressive and potentially fatal neoplasm. Several cutaneous malignancies have been described in association with porocarcinoma, including squamous cell carcinoma, basal cell carcinoma and tricholemmal carcinoma. Previous reports have indicated that the occurrence of malignant tumours in combination with porocarcinoma is extremely rare, in particular with regard to Bowen disease (BD). We report an uncommon case of porocarcinoma occurring synchronously in a single BD lesion in a 63‐year‐old woman with multiple BD lesions. The clinical and histological findings confirmed this diagnosis. 相似文献
63.
64.
Xiaoyan Lu Isabelle R. Miousse Sandra V. Pirela Jodene K. Moore Stepan Melnyk 《Nanotoxicology》2016,10(5):629-639
Evidence continues to grow on potential environmental health hazards associated with engineered nanomaterials (ENMs). While the geno- and cytotoxic effects of ENMs have been investigated, their potential to target the epigenome remains largely unknown. The aim of this study is two-fold: 1) determining whether or not industry relevant ENMs can affect the epigenome in vivo and 2) validating a recently developed in vitro epigenetic screening platform for inhaled ENMs. Laser printer-emitted engineered nanoparticles (PEPs) released from nano-enabled toners during consumer use and copper oxide (CuO) were chosen since these particles induced significant epigenetic changes in a recent in vitro companion study. In this study, the epigenetic alterations in lung tissue, alveolar macrophages and peripheral blood from intratracheally instilled mice were evaluated. The methylation of global DNA and transposable elements (TEs), the expression of the DNA methylation machinery and TEs, in addition to general toxicological effects in the lung were assessed. CuO exhibited higher cell-damaging potential to the lung, while PEPs showed a greater ability to target the epigenome. Alterations in the methylation status of global DNA and TEs, and expression of TEs and DNA machinery in mouse lung were observed after exposure to CuO and PEPs. Additionally, epigenetic changes were detected in the peripheral blood after PEPs exposure. Altogether, CuO and PEPs can induce epigenetic alterations in a mouse experimental model, which in turn confirms that the recently developed in vitro epigenetic platform using macrophage and epithelial cell lines can be successfully utilized in the epigenetic screening of ENMs. 相似文献
65.
Benyam Kinde Harrison W. Gabel Caitlin S. Gilbert Eric C. Griffith Michael E. Greenberg 《Proceedings of the National Academy of Sciences of the United States of America》2015,112(22):6800-6806
DNA methylation at CpG dinucleotides is an important epigenetic regulator common to virtually all mammalian cell types, but recent evidence indicates that during early postnatal development neuronal genomes also accumulate uniquely high levels of two alternative forms of methylation, non-CpG methylation and hydroxymethylation. Here we discuss the distinct landscape of DNA methylation in neurons, how it is established, and how it might affect the binding and function of protein readers of DNA methylation. We review studies of one critical reader of DNA methylation in the brain, the Rett syndrome protein methyl CpG-binding protein 2 (MeCP2), and discuss how differential binding affinity of MeCP2 for non-CpG and hydroxymethylation may affect the function of this methyl-binding protein in the nervous system. 相似文献
66.
Dynamic LVOT Obstruction and Aortic Stenosis in the Same Patient: A Case of Challenging Doppler Hemodynamics
下载免费PDF全文
![点击此处可从《Echocardiography (Mount Kisco, N.Y.)》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Matthew W. Parker M.D. Francis J. Kiernan M.D. 《Echocardiography (Mount Kisco, N.Y.)》2015,32(6):1030-1032
We present a patient with both dynamic left ventricular outflow tract obstruction and valvular aortic stenosis. The aortic valve was calcified, and velocities and gradients measured by continuous‐wave Doppler met standard criteria for severe aortic stenosis. The increased subvalvular velocities invalidated assumptions of the simplified Bernoulli equation; correction using the longer form of the Bernoulli equation suggested a lower but still significant gradient. The complex shape of the subvalvular spectral Doppler envelope indicated supranormal systolic function and dynamic left ventricular outflow obstruction. Left heart catheterization with an end‐hole catheter was required to determine the subvalvular and valvular components of the obstruction. 相似文献
67.
68.
C. Dessinioti C.C. Zouboulis V. Bettoli D. Rigopoulos 《Journal of the European Academy of Dermatology and Venereology》2020,34(10):2229-2240
Guidelines and consensus on the management of patients with acne aim to give evidence-based, expert-group recommendations. This review compares current guidelines and consensus articles to provide a compilation of recommendations on the treatment of acne with oral isotretinoin. Ten common, relevant, clinical questions are addressed, based on published recommendations, including the indications of isotretinoin, the proposed daily dose, the cumulative isotretinoin dose and the laboratory monitoring needed. Recommendations on special considerations are also addressed, including the timing of procedures and the question of an association of depression or inflammatory bowel disease with isotretinoin. A major limitation is the use of different classification systems for acne across guidelines. The recommended daily dose ranges from 0.3 to 0.5 mg/kg in the European guidelines to up to 1 mg/kg in the US guidelines. A specific duration of treatment of at least 6 months is only recommended in the European guidelines. All guidelines report the need of strict pregnancy prevention measures. The European, French and US guidelines recommend to monitor for symptoms of depression. Important clinical questions that are inconsistently addressed in guidelines include the age indication, the recommendation for a cumulative dose, the timing of procedures, the association of isotretinoin with IBD, the recommendation for preventing acne flares and for appropriate laboratory monitoring. These topics should be clearly included in the recommendations of guidelines as they are often raised in everyday clinical practice. 相似文献
69.
70.